本文選題：乳腺癌　切入點(diǎn)：改良根治術(shù)　出處：《昆明醫(yī)科大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

【摘要】：[目的]:比較左乳腺癌改良根治術(shù)后胸壁電子線照射、三維適形放療、X線和電子線混合三維適形放療三種治療方法的劑量學(xué)特點(diǎn)。[方法]:選取2014年1月至2015年5月昆明醫(yī)科大學(xué)第三附屬醫(yī)院收治的女性中晚期左側(cè)乳腺癌改良根治術(shù)后患者15例,左胸壁表面墊0. 5cm厚的等效填充物,熱塑體膜固定后行CT定位,用Pinnacle3 9. 10三維調(diào)強(qiáng)治療計(jì)劃系統(tǒng)對(duì)每位患者分別設(shè)計(jì)三種胸壁放射治療計(jì)劃:電子線照射計(jì)劃(E計(jì)劃)、3D-CRT照射計(jì)劃(3D-CRT計(jì)劃)、X線和電子線混合3D-CRT照射計(jì)劃(3D-CRT+E計(jì)劃),并對(duì)三種計(jì)劃靶區(qū)的劑量學(xué)參數(shù)如:PTV: V90、V95、V100、V105、V110、Dmax、Dmin、Dmean、D5、D95、CI、HI 和危及器官:左肺:V5、V10、V15、V20、V30、V40、Dmean;心臟:V5、V1o、V15、V20、V30、V40、Dmean;右肺:Dmean進(jìn)行評(píng)估和比較。[結(jié)果]:1. E計(jì)劃vs 3D-CRT計(jì)劃:(1)靶區(qū)劑量學(xué)比較:V90、V95、V100、V110、Dmax、Dmin、Dmean、D95、CI、HI 兩組比較差異均有統(tǒng)計(jì)學(xué)意義(P0.05) ; V105、D5兩組比較差異均無統(tǒng)計(jì)學(xué)意義(P0.05)。(2)危及器官劑量學(xué)比較:左肺:V5、V10、V15、V20,、V30、V40、Dmean、心臟:V5、V10、V15兩組比較差異均有統(tǒng)計(jì)學(xué)意義(P0. 05);右肺:Dmean、心臟:V20、V30、V40、Dmean兩組比較差異均無統(tǒng)計(jì)學(xué)意義(P0. 05)。2. E 計(jì)劃 vs 3D-CRT+E 計(jì)劃:(1)靶區(qū)劑量學(xué)比較:V90 V95、V100、V110、Dmax、Dmin、Dmean、D5、D95、CI、HI 兩組比較差異均有統(tǒng)計(jì)學(xué)意義(P0. 05) ; V105兩組比較差異無統(tǒng)計(jì)學(xué)意義(P0.05)。(2)危及器官劑量學(xué)比較:左肺:V5、V10、V15、V20、V30、V40、Dmean、心臟:V5、V10、V15兩組比較差異均有統(tǒng)計(jì)學(xué)意義(P0.05);右肺Dmean、心臟:V20、V30、V40、Dmean兩組比較差異均無統(tǒng)計(jì)學(xué)意義(P0.05)。3. 3D-CRT 計(jì)劃 vs 3D-CRT+E 計(jì)劃:(1)靶區(qū)劑量學(xué)比較:V105、Dmax、D5、CI兩組比較差異均有統(tǒng)計(jì)學(xué)意義(P0.05) ; V90、V95、V100、V110、Dm10、Dmmin、Dmean、D95、HI 兩組比較差異均無統(tǒng)計(jì)學(xué)意義(P0. 05)。(2)危及器官劑量學(xué)比較:左肺:V5、V10、心臟V5兩組比較差異均有統(tǒng)計(jì)學(xué)意義(P0.05);左肺:V15、V20、V30、V40、Dmean、右肺 Dmean、心臟:V10、V15、V20、V30、V40、Dmean兩組比較差異均無統(tǒng)計(jì)學(xué)意義(P0.05)。[結(jié)論]:胸壁單純電子線放療盡量不推薦常規(guī)使用。三維適形放療靶區(qū)的適形性、均勻性及對(duì)危及器官的保護(hù)方面均較單純電子線計(jì)劃有明顯提高,且臨床容易實(shí)施。3D-CRT+E計(jì)劃并沒有顯示出混合射線的明顯優(yōu)勢(shì)。因此,乳腺癌術(shù)后胸壁放療建議根據(jù)患者的實(shí)際情況制定個(gè)體化治療方案。
[Abstract]:[objective]: to compare the electron irradiation of chest wall after modified radical mastectomy for left breast cancer. Dosimetric characteristics of three dimensional conformal radiotherapy combined with three-dimensional conformal radiotherapy. [methods]: from January 2014 to May 2015, the left breast of female patients admitted to the third affiliated Hospital of Kunming Medical University was selected. There were 15 patients with adenocarcinoma after modified radical mastectomy. The thickness of the left chest wall was 0.5 cm thick. The thermoplastic membrane was fixed with CT. Three kinds of chest wall radiotherapy plans were designed for each patient by using Pinnacle3 910 three dimensional intensity modulated treatment plan system: electron line irradiation plan E plan 3D-CRT radiation plan 3D-CRT plan 3D-CRT radiation plan and 3D-CRT hybrid 3D-CRT radiation plan 3D-CRT plan. Dosimetric parameters of three planned target areas such as: V90V95V95V100V105V110DmaxDminD5D95CIHI and dangerous organs: left lung: V5V10V10V15V20V30V40Dmean; heart V5V1: V15V20V30V40Dmean; right lung Dmean. [results] 1e vs 3D-CRT. No significant difference was found between the two groups (P < 0.05); there was no significant difference between the two groups (P 0.05). 2) the dosimetry comparison of the organs of the two groups was not statistically significant. There was no significant difference between the two groups (P 0. 05). There was no significant difference between the two groups (P 0. 05), and there was no significant difference between the two groups (P 0. 05). The difference between the two groups was not statistically significant (P 0. 05), but there was no significant difference between the two groups (P < 0. 05). Comparison of dosimetry of target area between the two groups: 1: V90 V95N V100 D110DmaxDmin Dmean D5D95CIHI); V105 has no significant difference between the two groups (P0.05. 2) comparison of organ dosimetry: left lung V5V10V15 V20V30V40Dmean, heart V5V10V10V15 compared with V10V15V30V40Dmean, heart V5V10V10V15 compared with V10V15V10V30V40Dmean, heart V5V10V10V15 compared with V10V15V10V30V40Dmean, V10V15 V10V15 compared with V10V15V30V40Dmean, V10V10V15 V10V15 compared with V10V15V30V40Dmean, V10V10V15. There was no significant difference between the two groups in Dmean of right lung, Dmean of right lung, V30 / V20 / V40Dmean of the right lung. There was no significant difference between the two groups in Dmean (P0.05) .3.3D-CRT vs V3D-CRE (1)) the difference of dosimetry in target area between the two groups was significant (P0.05); there was significant difference between the two groups (P < 0.05); There was no significant difference in dosimetry between the two groups. There was no significant difference between the two groups (P < 0.05). There was no significant difference between the two groups (P < 0.05). There was no significant difference between the two groups. [conclusion] there was no significant difference between the two groups. [conclusion]: the left lung: V15V20 V30 V40Dmean, the right lung Dmean, the heart V10V15V15V20V30V40Dmean have no statistical significance. [conclusion]: the chest wall is pure. Electron line radiotherapy is not recommended for conventional use as far as possible. Conformability of three-dimensional conformal radiotherapy target, The uniformity and protection of organ endangering organs were significantly improved than those of the simple electron line program, and the clinical easy implementation of the .3D-CRT E program did not show the obvious advantages of mixed radiation. Postoperative chest wall radiotherapy for breast cancer suggests individualized treatment according to the actual conditions of the patients.
【學(xué)位授予單位】：昆明醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R737.9

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 韓彥輝;李向平;賀會(huì)江;閆俊麗;張高高;;浸潤(rùn)性乳腺癌保乳術(shù)后常規(guī)分割放療與大分割放療的療效比較[J];山西醫(yī)藥雜志;2014年23期

2 李文博;孟濤;成芳;;乳腺癌術(shù)后胸壁復(fù)發(fā)的臨床分析:附113例報(bào)告[J];中國(guó)普通外科雜志;2014年11期

3 趙淑紅;曹席明;劉國(guó)強(qiáng);高暉;于嬌;王青;;乳腺癌改良根治術(shù)后大分割放療的研究[J];現(xiàn)代腫瘤醫(yī)學(xué);2014年09期

4 張敏敏;莫軍揚(yáng);黃平;莊亞強(qiáng);唐中華;;35歲以下女性乳腺癌患者臨床病理特征分析:附85例報(bào)告[J];中國(guó)普通外科雜志;2014年05期

5 趙宗興;楊建征;張亞男;;乳腺癌術(shù)后大分割放療研究進(jìn)展[J];中國(guó)臨床醫(yī)生;2014年05期

6 武二偉;邢愛民;趙靜;王子俊;;乳腺癌根治術(shù)后大分割放療與常規(guī)分割放療的效果比較[J];實(shí)用醫(yī)藥雜志;2014年01期

7 郭峰;侯信明;任立軍;孫清慧;王春鋒;;保乳術(shù)與改良根治術(shù)對(duì)育齡期乳腺癌患者復(fù)發(fā)及生存情況的影響[J];中國(guó)普通外科雜志;2013年11期

8 趙雪桃;金保紅;陳文璞;;乳腺癌改良根治術(shù)聯(lián)合化療對(duì)患者并發(fā)癥與生活質(zhì)量的影響[J];中國(guó)普通外科雜志;2013年11期

9 張慕娟;湯亞莉;周素珠;丁春江;陳沃培;;乳腺癌術(shù)后三維適形放療致放射性肺炎相關(guān)因素分析[J];中國(guó)醫(yī)藥科學(xué);2013年21期

10 楊倩;朱慶莉;姜玉新;戴晴;;乳腺癌改良根治術(shù)后局部胸壁復(fù)發(fā)的臨床特征與超聲表現(xiàn)[J];中華醫(yī)學(xué)超聲雜志(電子版);2013年08期

，

本文編號(hào)：1625782